Constitución, salud y medicamentos
CUADERNOS DE DERECHO FARMACÉUTICO Nº 89 APRIL-JUNE 2024
This article analyzes to what extent the obstacles or difficulties to access to medicines not included in the pharmaceutical provision of the National Health System have constitutional significance. It concludes that in this field there is a lack of legal certainty and a deficient publicity of the applicable rules which is hardly compatible with the... Read More
Valoraciones sobre el proyecto de reforma de la publicidad de productos sanitarios
CUADERNOS DE DERECHO FARMACÉUTICO Nº 89 APRIL-JUNE 2024
The purpose of this article is to analyse the current regulatory framework for the advertising of medical devices and the changes that will be generated by the adoption of the new Royal Decree on the advertising of medical devices, which was submitted for public consultation in February 2024. It also analyses the impact that the... Read More
Faus Moliner, Best Life Sciences Law Firm in Spain at the IX edition of Expansión Jurídico Awards 2024
The awards ceremony took place in Madrid on June 22
Faus Moliner has once again been recognized as the best law firm in Spain in the Life Sciences category at the IX Edition of the Expansión Jurídico Awards. The aim of these awards is to recognize the work of lawyers and law firms that have stood out for their special contribution to the legal and... Read More
¡Regulando a toda marcha!
El Global
La semana pasada el Ministerio de Sanidad publicó en audiencia pública el Proyecto de Real Decreto por el que se regula el procedimiento de financiación selectiva de productos sanitarios para pacientes no hospitalizados, uno de los once Reales Decretos que el Ministerio de Sanidad prevé aprobar en 2024. Esta norma tiene como objeto la actualización... Read More
Loss of opportunity is compensable in public procurement
Judgment of the Court of Justice of the European Union of 6 June 2024 (C-547/22)
Capsulas Nº 253
How many times have you heard that “the important thing is to participate”? Whoever said it surely did not think that a judgment of the Court of Justice of the European Union (CJEU) would ever uphold their thesis. Or, at the very least, that it would point out that Member States cannot exclude at first... Read More
Payment-by-results agreements and public procurement rules
Reflections under public procurement regulations
Capsulas Nº 253
In recent years, payment-by-results models have proliferated for the incorporation of therapeutic innovations into public funding. The same is true for the acquisition of these innovations by regional health systems and/or hospitals. Although there is a certain consensus on the advantages of these models, especially in a context of therapeutic advances with very high expectations... Read More
Practical aspects on the new Catalan Guide on Advertising of Medicinal Products
Informative session by the Catalan Medicinal Products Surveillance and Advertising Section on 28 May 2024
Capsulas Nº 253
On 28 May, the Medicinal Products Surveillance and Advertising Section of the Catalan Government organised an explanatory session on the new features of the latest version of the Catalan Guide on Advertising of Medicinal Products for Human Use, published in February 2024. The session included a practical Q&A section where the participants raised numerous questions.... Read More
Tiempo de pactos
El Global
Ahora que empieza de verdad la legislatura, que tal vez tengamos un par de años sin contiendas electorales (no creo que lo que suceda en Catalunya haga descarrilar ningún tren) parece que soplan vientos a favor de los pactos. Populares y socialistas han llegado a acuerdos institucionales relevantes en la Unión Europea, y se ha... Read More
Incentivos, innovación y seguridad jurídica
El Global
La semana pasada empezó fuerte. El lunes, la Fundación CEFI organizó, con su habitual maestría, un seminario sobre los incentivos a la innovación en salud como ventaja competitiva de la UE. En la primera mesa, moderada por Silvia Martínez (BMS), se trataron cuestiones relacionadas con el marco actual y la importancia de los incentivos (Irene... Read More
Más certidumbre en la compra pública
El Global
Es frecuente leer o escuchar que la normativa de contratación pública es un corsé que no se ajusta como debería a la compra de medicamentos y productos sanitarios. Dicho desorden o desajuste va siendo moldeado mediante las interpretaciones razonadas y razonables que sobre la Ley de Contratos del Sector Público (LCSP) hacen los tribunales administrativos... Read More